AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ANTX…

AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

AN2 Therapeutics, Inc.

ANTX · CIK 1880438

4 · Nov 6, 2025 · Prior Stephen David sold 765 shares at $1.14/share ($872)

4

Prior Stephen David sold 765 shares at $1.14/share ($872)

Filed: Nov 6, 2025
Period: Nov 4, 2025
Accession: 0001193125-25-270252
Filer: AN2 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov